ASCO 2019: Form Biomarker Discovery to Photo-Immunotherapy

ASCO 2019: Form Biomarker Discovery to Photo-Immunotherapy

0 0 hace 5 meses
In this episode of the Onco’Zine Brief Peter Hofland reports from the 2019 annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019.

Hofland talks with:

- Dr. Hartmut Juhl, the Chief Executive Officer of Indivumed, a physician-led, integrated global oncology company. The company offers specialized products and services designed to support the discovery of biomarkers, drug development, clinical trials, and individualized treatment for ... Más informaciones

Síguenos en Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Help